| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of General Virology, Vol 79, 1069-1081, Copyright © 1998 by Society for General Microbiology
ARTICLES |
I Huvent, SS Hong, C Fournier, B Gay, J Tournier, C Carriere, M Courcoul, R Vigne, B Spire and P Boulanger
Laboratoire de Virologie Moleculaire et Pathogenese Virale (CNRS UMR- 5812), Institut de Biologie, Faculte de Medecine, Montpellier, France.
Human immunodeficiency virus type 1 (HIV-1) wild-type (WT) virion infectivity factor (Vif) protein (Vifwt) and full-length Gag precursor (Pr55Gag) were found to be co-encapsidated into extracellular, membrane- enveloped virus-like particles released by budding from Sf9 cells co- expressing the two recombinant proteins in trans, with an average copy number of 3.5+/-0.6 Vifwt per 100 Pr55Gag molecules. No preferential localization at the plasma membrane was observed for recombinant Vif in the absence of Gag expression, and a significant proportion of Vif accumulated within the nucleus. Two conserved motifs, W89RKRRY94 and P156KKIKP161, seemed to act as nuclear addressing signals. The Pr55Gag and Vifwt interacting domains were analysed by biopanning of a phage- displayed hexapeptide library. The Vif-binding domain, which spanned residues H421-T470 in Pr55Gag, corresponded to the C-terminal region of nucleocapsid (NC), including the second zinc finger, the intermediate spacer peptide sp2 and the N-terminal half of the p6 domain. Deletions in these Gag domains significantly decreased the Vif encapsidation efficiency, and complete deletion of NC abolished Vif encapsidation. In Vif, four discrete Gag-binding sites were identified, within residues T68-L81 (site I) and W89-P100 (site II) in the central domain, and within residues P162-R173 (III) and P177-M189 (IV) at the C terminus. Substitutions in site I and deletion of site IV were detrimental to Vif encapsidation, whereas substitution of basic residues for alanine in sites III and IV had a positive effect. The data suggest a direct intracellular Gag-Vif interaction and the occurrence of a Pr55Gag- mediated membrane-targeting pathway for Vif in Sf9 cells.
This article has been cited by other articles:
|
|
 |
|
  P. Henning, E. Lundgren, M. Carlsson, K. Frykholm, J. Johannisson, M. K. Magnusson, E. Tang, L. Franqueville, S. S. Hong, L. Lindholm, et al. Adenovirus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3151 - 3160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vellinga, S. Van der Heijdt, and R. C. Hoeben The adenovirus capsid: major progress in minor proteins J. Gen. Virol., June 1, 2005; 86(6): 1581 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Ribeiro, A. Maia e Silva, M. Santa-Marta, A. Pombo, J. Moniz-Pereira, J. Goncalves, and I. Barahona Functional Analysis of Vif Protein Shows Less Restriction of Human Immunodeficiency Virus Type 2 by APOBEC3G J. Virol., January 15, 2005; 79(2): 823 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Luo, B. Liu, Z. Xiao, Y. Yu, X. Yu, R. Gorelick, and X.-F. Yu Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging J. Virol., November 1, 2004; 78(21): 11841 - 11852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Feng, A. Davis, J.-A. Lake, J. Carr, W. Xia, C. Burrell, and P. Li Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif J. Virol., October 1, 2004; 78(19): 10574 - 10581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman The Interaction between HIV-1 Gag and APOBEC3G J. Biol. Chem., August 6, 2004; 279(32): 33177 - 33184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Akari, M. Fujita, S. Kao, M. A. Khan, M. Shehu-Xhilaga, A. Adachi, and K. Strebel High Level Expression of Human Immunodeficiency Virus Type-1 Vif Inhibits Viral Infectivity by Modulating Proteolytic Processing of the Gag Precursor at the p2/Nucleocapsid Processing Site J. Biol. Chem., March 26, 2004; 279(13): 12355 - 12362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Violot, S. S. Hong, D. Rakotobe, C. Petit, B. Gay, K. Moreau, G. Billaud, S. Priet, J. Sire, O. Schwartz, et al. The Human Polycomb Group EED Protein Interacts with the Integrase of Human Immunodeficiency Virus Type 1 J. Virol., December 1, 2003; 77(23): 12507 - 12522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Gaddis, E. Chertova, A. M. Sheehy, L. E. Henderson, and M. H. Malim Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions J. Virol., May 15, 2003; 77(10): 5810 - 5820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kao, H. Akari, M. A. Khan, M. Dettenhofer, X.-F. Yu, and K. Strebel Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection J. Virol., December 20, 2002; 77(2): 1131 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Baraz, M. Hutoran, I. Blumenzweig, M. Katzenellenbogen, A. Friedler, C. Gilon, M. Steinitz, and M. Kotler Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region J. Gen. Virol., September 1, 2002; 83(9): 2225 - 2230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Khan, H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel Intravirion Processing of the Human Immunodeficiency Virus Type 1 Vif Protein by the Viral Protease May Be Correlated with Vif Function J. Virol., August 12, 2002; 76(18): 9112 - 9123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bardy, B. Gay, S. Pebernard, N. Chazal, M. Courcoul, R. Vigne, E. Decroly, and P. Boulanger Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing J. Gen. Virol., November 1, 2001; 82(11): 2719 - 2733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Khan, C. Aberham, S. Kao, H. Akari, R. Gorelick, S. Bour, and K. Strebel Human Immunodeficiency Virus Type 1 Vif Protein Is Packaged into the Nucleoprotein Complex through an Interaction with Viral Genomic RNA J. Virol., August 15, 2001; 75(16): 7252 - 7265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Magnusson, S. S. Hong, P. Boulanger, and L. Lindholm Genetic Retargeting of Adenovirus: Novel Strategy Employing ""Deknobbing"" of the Fiber J. Virol., August 15, 2001; 75(16): 7280 - 7289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sova, D. J. Volsky, L. Wang, and W. Chao Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed Gag J. Virol., June 15, 2001; 75(12): 5504 - 5517. [Abstract] [Full Text]
|
|
|
|
|
|
A. Öhagen and D. Gabuzda Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core J. Virol., December 1, 2000; 74(23): 11055 - 11066. [Abstract] [Full Text]
|
|
|
|
|
|
H. Zhang, R. J. Pomerantz, G. Dornadula, and Y. Sun Human Immunodeficiency Virus Type 1 Vif Protein Is an Integral Component of an mRNP Complex of Viral RNA and Could Be Involved in the Viral RNA Folding and Packaging Process J. Virol., September 15, 2000; 74(18): 8252 - 8261. [Abstract] [Full Text]
|
|
|
|
|
|
R. Peytavi, S. S. Hong, B. Gay, A. D. d'Angeac, L. Selig, S. Benichou, R. Benarous, and P. Boulanger HEED, the Product of the Human Homolog of the Murine eed Gene, Binds to the Matrix Protein of HIV-1 J. Biol. Chem., January 15, 1999; 274(3): 1635 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, Y. Sun, and H. Zhang The Multimerization of Human Immunodeficiency Virus Type I Vif Protein. A REQUIREMENT FOR Vif FUNCTION IN THE VIRAL LIFE CYCLE J. Biol. Chem., February 9, 2001; 276(7): 4889 - 4893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hassaine, M. Courcoul, G. Bessou, Y. Barthalay, C. Picard, D. Olive, Y. Collette, R. Vigne, and E. Decroly The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif Protein J. Biol. Chem., May 11, 2001; 276(20): 16885 - 16893. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
